1. Home
  2. RGLS vs SMXT Comparison

RGLS vs SMXT Comparison

Compare RGLS & SMXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGLS
  • SMXT
  • Stock Information
  • Founded
  • RGLS 2007
  • SMXT 2008
  • Country
  • RGLS United States
  • SMXT United States
  • Employees
  • RGLS N/A
  • SMXT N/A
  • Industry
  • RGLS Biotechnology: Pharmaceutical Preparations
  • SMXT
  • Sector
  • RGLS Health Care
  • SMXT
  • Exchange
  • RGLS Nasdaq
  • SMXT NYSE
  • Market Cap
  • RGLS 102.8M
  • SMXT 145.0M
  • IPO Year
  • RGLS 2012
  • SMXT 2024
  • Fundamental
  • Price
  • RGLS $1.46
  • SMXT $1.49
  • Analyst Decision
  • RGLS Strong Buy
  • SMXT
  • Analyst Count
  • RGLS 6
  • SMXT 0
  • Target Price
  • RGLS $10.33
  • SMXT N/A
  • AVG Volume (30 Days)
  • RGLS 306.9K
  • SMXT 399.3K
  • Earning Date
  • RGLS 08-08-2024
  • SMXT 11-05-2024
  • Dividend Yield
  • RGLS N/A
  • SMXT N/A
  • EPS Growth
  • RGLS N/A
  • SMXT N/A
  • EPS
  • RGLS N/A
  • SMXT N/A
  • Revenue
  • RGLS N/A
  • SMXT $36,735,765.00
  • Revenue This Year
  • RGLS N/A
  • SMXT N/A
  • Revenue Next Year
  • RGLS N/A
  • SMXT N/A
  • P/E Ratio
  • RGLS N/A
  • SMXT N/A
  • Revenue Growth
  • RGLS N/A
  • SMXT N/A
  • 52 Week Low
  • RGLS $1.08
  • SMXT $0.91
  • 52 Week High
  • RGLS $3.79
  • SMXT $15.88
  • Technical
  • Relative Strength Index (RSI)
  • RGLS 37.78
  • SMXT N/A
  • Support Level
  • RGLS $1.50
  • SMXT N/A
  • Resistance Level
  • RGLS $1.72
  • SMXT N/A
  • Average True Range (ATR)
  • RGLS 0.13
  • SMXT 0.00
  • MACD
  • RGLS -0.01
  • SMXT 0.00
  • Stochastic Oscillator
  • RGLS 14.29
  • SMXT 0.00

About RGLS Regulus Therapeutics Inc.

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

About SMXT SOLARMAX TECHNOLOGY INC

SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.

Share on Social Networks: